Age-Related Macular Degeneration - Quest Diagnostics Patient Health Library Age-Related Macular Degeneration Medications Currently there are few proven drug treatments for age-related macular degeneration (AMD), but researchers are studying new medicines.
Archemix Announces Milestone Achievement with Candidate Selection by Eyetech as Part of Broad Collaboration to Discover and The pre-clinical candidate selected by Eyetech is an aptamer directed against the target Platelet Derived Growth Factor-B (PDGF-B) for potential use in neovascular age-related macular degeneration (neovascular AMD).- In addition to uses as a single agent, pre-clinical studies have also demonstrated that aptamers directed against PDGF-B may provide additional benefit when used in...
tgAAVCF: Will The Latest Failure Be The Straw That Breaks Investor’s Backs? - - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
Database P P - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products To purchase documents on-line click on- -link attached to selected document!- The fee is $15 per document Documents are delivered by e-mail...
Database M M - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products.Macugen ™...
http://www.phrma.org/newmedicines/resources/2003-09-02.117.pdf Pars Laboratories glaucoma Phase II Concord, MA ISV- 205 InSite Vision steroid glaucoma Phase II completed Alameda, CA (510) 865- 8800 Lucentis Genentech age- related macular degeneration Phase III ranibizumab South San Francisco, CA (wet form) (650) 225- 1000 Macugen Eyetech Pharmaceuticals macular degeneration Phase II/ III pegaptanib sodium New York, NY (212) 997- 9241...
http://www.phrma.org/newmedicines/resources/2003-09-02.117.pdf page 8
Approved Products_2004.xls 194 Jul- 02 Aranes p hyperglycosylated erythropoietin Chemotherapy- induced anemia Amgen 195 Jul- 02 X yrem Sodium oxybate oral solution Cataplexy associated with narcolepsy Orphan Medical 196 Au g- 02 Prestara Prasterone Lupus Genelabs 197 Se p- 02 Hepsera Adefovir dipivoxil Chronic Hepatitus B Gilead 198 Nov- 02 Mitoz ytrex Generic mitomycin Disseminated adenocarcinoma of the...
author: Reijer
Approved Products_2004.xls page 5
author: Reijer
http://www.adis.com/files/newsletters/INP/Icov1437.pdf 24 Paediatric influenza vaccination guidelines released 4 CANCER Potential HIV treatment that targets host- cell pathway 11 Anti- EGFR mab 806 entering clinical trials 3 Cisplatin + radiotherapy in head and neck cancer 14 MUSCULOSKELETAL Fulvestrant launched in the UK 21 Infliximab + methotrexate in refractory RA 15 Ibandronic acid in metastatic bone disease 15 Methotrexate ±...
http://www.adis.com/files/newsletters/INP/Icov1428.pdf 24 Telithromycin pharmacokinetics promising for RTIs 19 CANCER Varicella vaccine: National programme worth it in Israel 5 Aldesleukin- based regimens in renal cancer 15 Viramidine as effective as ribavirin in hepatitis C 10 CC 5013 receives European orphan drug status 21 Chlamydia screening cost effective for adolescent detainees 5 Cisplatin, epirubicin, vinorelbine in breast cancer...
